PALM BEACH, Fla., July 25, 2012 — The Genetics Policy Institute (GPI) announced that it has joined with the Oakland University William Beaumont Institute for Stem Cell and Regenerative Medicine (ISCRM) as an organizing partner of the Second Midwest Conference on Stem Cell Biology and Therapy October 5-7, 2012 in Rochester, Michigan.
“GPI is proud to partner with ISCRM in this important scientific conference, which will showcase the latest discoveries from top laboratories around the region and beyond. We take pride that ISCRM was officially launched at our 2010 World Stem Cell Summit in Detroit. GPI’s support for this conference underscores our continuing commitment to advance stem cell research in the Midwest,” said Bernard Siegel, GPI’s Executive Director and founder of the annual World Stem Cell Summit.
Researchers from hospitals, medical organizations, academic institutions and the business community throughout the country will discuss not only the latest advances in this rapidly expanding field of medical science, but the ethical and moral issues that surround it.
“There are unlimited opportunities in the rapidly progressing areas of stem cell biology and regenerative medicine,” said Dr. Rasul Chaudhry, director of the ISCRM. “This conference is a great way to showcase not only Oakland University, Beaumont Health System, and ISCRM but the strength of academics and research in Michigan as a whole.
The conference is open to the public, and physicians, nurses, physical therapists, occupational therapists and others in health care professions may be able to earn continuing medical education credits by attending.
Early registration, which runs through Wednesday, Aug. 15, is $300 for the public and $150 for students, residents and post-doctoral students. Registration after Aug. 15 is $350 and $175 respectively. Optional workshops are $100. Sponsorship opportunities are still available.
For more information on the Second Midwest Conference on Stem Cell Biology and Therapy, visit the website at www.oakland.edu/scbt.
About Genetics Policy Institute (GPI): GPI is a 501c3 nonprofit foundation with the mission to promote and defend stem cell research and its application in medicine to develop therapeutics and cures for many otherwise intractable diseases and disorders. GPI pursues this mission through production of its flagship annual World Stem Cell Summit, publication of the World Stem Cell Report, the Stem Cell Action Awards, special projects, speaking engagements, teaching initiatives and strategic collaborations.
About the World Stem Cell Summit: The global stem cell community will converge December 3-5, 2012 at the 8th World Stem Cell Summit, held at the Palm beach County Convention Center in West Palm Beach, Florida USA, to chart the future of regenerative medicine. By sharing knowledge and advancing collaborations, the Summit is an engine for discovery, funding and commercialization. Planned by and for the stem cell and regenerative medicine community, the Summit brings global stakeholders together to solve global challenges. The goal of the Summit is to accelerate the discovery and development of lifesaving cures and therapies. The Summit builds a foundation to advance cell therapies by establishing a supportive environment of regulation, legislation, financing, reimbursement and patient advocacy. For more information about the World Stem Cell Summit, please visit www.worldstemcellsummit.com.
